Concourse Financial Group Securities, Inc. Avita Medical, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$7.72 - $10.87 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$7.92 - $15.55 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$12.56 - $18.31 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$9.29 - $14.57 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$13.84 - $20.79 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$13.84 - $20.79 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$10.7 - $17.48 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$6.45 - $14.48 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$4.53 - $7.55 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$4.97 - $7.89 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$4.6 - $8.82 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	SELL	$6.96 - $12.15 $1,392 - $2,430	-200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$26.1 - $34.6 $5,220 - $6,920	200 New	200 $6,000

Others Institutions Holding RCEL

# of Institutions

Shares Held

5.96M

Call Options Held

35.5K

Put Options Held

38K

Black Rock Inc. New York, NY

1.78M
Shares

$20.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.42M
Shares

$16.3 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

594K
Shares

$6.82 Million
0.0% of portfolio
State Street Corp Boston, MA

520K
Shares

$5.97 Million
0.0% of portfolio
Essex Investment Management CO LLC Boston, MA

231K
Shares

$2.65 Million
0.46% of portfolio

View Full List

About AVITA Medical, Inc.

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $287M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

More about RCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account